Inotiv, Inc. (NASDAQ:NOTV - Get Free Report) CEO Robert Jr. Leasure sold 22,700 shares of the firm's stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $4.15, for a total transaction of $94,205.00. Following the transaction, the chief executive officer now directly owns 1,030,209 shares of the company's stock, valued at approximately $4,275,367.35. This trade represents a 2.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Inotiv Price Performance
Shares of NASDAQ:NOTV traded down $0.41 on Friday, hitting $3.51. The company had a trading volume of 1,090,696 shares, compared to its average volume of 575,865. The company has a current ratio of 1.37, a quick ratio of 1.22 and a debt-to-equity ratio of 2.29. The company has a market cap of $91.30 million, a PE ratio of -0.76 and a beta of 3.58. Inotiv, Inc. has a 52-week low of $1.23 and a 52-week high of $11.42. The business has a 50 day moving average of $4.43 and a 200 day moving average of $2.82.
Inotiv (NASDAQ:NOTV - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.32) by ($0.10). Inotiv had a negative net margin of 25.40% and a negative return on equity of 15.07%. As a group, equities analysts anticipate that Inotiv, Inc. will post -0.73 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Inotiv
A number of institutional investors have recently bought and sold shares of NOTV. Bay Colony Advisory Group Inc d b a Bay Colony Advisors purchased a new stake in Inotiv during the fourth quarter worth approximately $60,000. AlphaCentric Advisors LLC acquired a new position in shares of Inotiv in the 4th quarter worth approximately $163,000. Renaissance Technologies LLC grew its holdings in shares of Inotiv by 29.9% during the second quarter. Renaissance Technologies LLC now owns 164,164 shares of the company's stock valued at $273,000 after purchasing an additional 37,800 shares during the last quarter. Calamos Advisors LLC bought a new position in shares of Inotiv during the fourth quarter worth about $275,000. Finally, Geode Capital Management LLC increased its stake in shares of Inotiv by 7.7% in the third quarter. Geode Capital Management LLC now owns 250,895 shares of the company's stock valued at $427,000 after purchasing an additional 18,039 shares during the period. 18.17% of the stock is currently owned by hedge funds and other institutional investors.
Inotiv Company Profile
(
Get Free Report)
Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.
Featured Stories
Before you consider Inotiv, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Inotiv wasn't on the list.
While Inotiv currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
